Loading...
XCSEBRAINP
Market cap2mUSD
Dec 23, Last price  
0.09DKK
1D
11.00%
1Q
11.00%
IPO
-98.10%
Name

Brain+ A/S

Chart & Performance

D1W1MN
XCSE:BRAINP chart
P/E
P/S
8.02
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
Rev. gr., 5y
-17.14%
Revenues
2m
-27.23%
2,699,9901,973,5964,342,9386,021,4575,272,0006,009,0003,992,2143,232,6172,352,491
Net income
-19m
L+97.58%
-447,814-389,776-582,787-462,187-1,513,000-1,279,000-7,079,752-9,679,595-19,124,815
CFO
-14m
L+240.52%
00016,3127,290,898-8,382,370-4,025,370-13,707,331
Earnings
May 22, 2025

Profile

Brain+ A/S develops digital therapeutics for Alzheimer's and dementia. The company develops cognitive stimulation therapy (CST), a therapy that treats the main symptoms of dementia; Computerized Cognitive Training, a cognitive training method for patients with mild cognitive impairment; and Starry Night, memory test for early detection and monitoring of Alzheimer's. In addition, it develops an interface for clinicians to track and trace the patient's treatment progress. The company was incorporated in 2012 and is based in Copenhagen, Denmark. Brain+ A/S was formerly a subsidiary of Brain+ Holding ApS.
IPO date
Oct 07, 2021
Employees
Domiciled in
DK
Incorporated in
DK

Valuation

Title
DKK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,352
-27.23%
3,233
-19.03%
3,992
-33.56%
Cost of revenue
3,921
(11,095)
(8,058)
Unusual Expense (Income)
NOPBT
(1,569)
14,327
12,051
NOPBT Margin
443.21%
301.86%
Operating Taxes
(628)
(1,435)
(2,025)
Tax Rate
NOPAT
(941)
15,762
14,076
Net income
(19,125)
97.58%
(9,680)
36.72%
(7,080)
453.54%
Dividends
Dividend yield
Proceeds from repurchase of equity
17,294
6,396
27,456
BB yield
-227.93%
-20.00%
-100.57%
Debt
Debt current
(2,735)
87
Long-term debt
(21,044)
Deferred revenue
18,691
21,353
21,044
Other long-term liabilities
594
546
734
Net debt
(3,091)
(9,137)
(31,036)
Cash flow
Cash from operating activities
(13,707)
(4,025)
(8,382)
CAPEX
(3,513)
(5,024)
(7,358)
Cash from investing activities
(3,513)
(5,024)
(7,358)
Cash from financing activities
13,910
5,458
24,371
FCF
(2,240)
5,440
(19,427)
Balance
Cash
3,091
6,402
9,993
Long term investments
Excess cash
2,974
6,240
9,793
Stockholders' equity
(12,226)
16,383
20,604
Invested Capital
43,895
29,306
11,545
ROIC
77.17%
ROCE
40.31%
55.29%
EV
Common stock shares outstanding
39,112
18,703
7,983
Price
0.19
-88.65%
1.71
-50.00%
3.42
 
Market cap
7,588
-76.27%
31,982
17.14%
27,301
 
EV
4,496
22,844
(3,735)
EBITDA
2,366
15,955
13,657
EV/EBITDA
1.90
1.43
Interest
47
1,942
Interest/NOPBT
0.33%
16.11%